S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Perceptive Advisors/Q4 2022

Perceptive Advisors

Period: Q4 2022 Β· Filed: 2023-02-14
View on SEC EDGAR β†—
AUM
$3.56B
Total portfolio value
Positions
96
Reported securities
Top Holding
FOLD
9.5% $337.5M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2023-02-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
FOLDAMICUS THERAPEUTICS INC$337.5M9.48%β€”β€”
9.5%
AMLXAMYLYX PHARMACEUTICALS INC$225.0M6.32%$35.98$18.27-49.2%
6.3%
MDGLMADRIGAL PHARMACEUTICALS INC$212.4M5.97%$285.42$528.10+85.0%
6.0%
CERECEREVEL THERAPEUTICS HLDNG I$205.4M5.77%β€”β€”
5.8%
RXDXPROMETHEUS BIOSCIENCES INC$133.4M3.75%β€”β€”
3.8%
VRNAVERONA PHARMA PLC$127.5M3.58%β€”β€”
3.6%
HZNPHORIZON THERAPEUTICS PUB L$109.3M3.07%β€”β€”
3.1%
MRTXMIRATI THERAPEUTICS INC$99.3M2.79%β€”β€”
2.8%
LIANYLIANBIO$94.4M2.65%$0.00$0.12
2.6%
MDGLPUTMADRIGAL PHARMACEUTICALS INC$87.1M2.45%$285.42$528.10+85.0%
2.5%
SRPTSAREPTA THERAPEUTICS INC$84.1M2.36%$124.84$19.28-84.6%
2.4%
INBXINHIBRX INC$81.7M2.29%β€”$97.58
2.3%
ACLXARCELLX INC$80.5M2.26%$31.03β€”
2.3%
ALDXALDEYRA THERAPEUTICS INC$79.0M2.22%$6.96$2.27-67.4%
2.2%
XENEXENON PHARMACEUTICALS INC$75.8M2.13%$37.26$60.96+63.6%
2.1%
CRNXCRINETICS PHARMACEUTICALS IN$73.9M2.08%$18.10$42.23+133.3%
2.1%
BLUBELLUS HEALTH INC NEW$73.1M2.05%β€”β€”
2.0%
SWTXSPRINGWORKS THERAPEUTICS INC$68.1M1.91%β€”β€”
1.9%
NUVLNUVALENT INC$67.2M1.89%$28.97$123.73+327.1%
1.9%
IOVAIOVANCE BIOTHERAPEUTICS INC$63.7M1.79%$6.11$4.31-29.5%
1.8%
PCVXVAXCYTE INC$56.1M1.58%$47.20$58.39+23.7%
1.6%
BMRNBIOMARIN PHARMACEUTICAL INC$52.4M1.47%$100.61$58.99-41.4%
1.5%
ADMAADMA BIOLOGICS INC$46.2M1.30%$3.87$8.95+131.3%
1.3%
MGTXMEIRAGTX HLDGS PLC$45.4M1.27%$6.48$13.92+114.8%
1.3%
TMCITREACE MEDICAL CONCEPTS INC$44.8M1.26%$22.39$4.21-81.2%
1.3%
VERUXXXXVERU INC$41.5M1.17%β€”β€”
1.2%
ALBOALBIREO PHARMA INC$38.0M1.07%β€”β€”
1.1%
COGTCOGENT BIOSCIENCES INC$37.1M1.04%$11.07$38.69+249.5%
1.0%
VRDNVIRIDIAN THERAPEUTICS INC$35.6M1.00%$28.50$19.40-31.9%
1.0%
RAPTRAPT THERAPEUTICS INC$35.6M1.00%β€”β€”
1.0%

Quarter-on-Quarter Activity

Q4 2022 vs. Q3 2022

New Positions (8)

TickerIssuerNotionalSince Filing
HZNPHORIZON THERAPEUTICS PUB L$109.3M
PCVXVAXCYTE INC$56.1M+23.7%
ZYMEZYMEWORKS DEL INC$35.5M
ACRVACRIVON THERAPEUTICS INC$34.6M
SLDBSOLID BIOSCIENCES INC$18.8M
ROIVROIVANT SCIENCES LTD$15.8M
ISRGINTUITIVE SURGICAL INC$10.6M
SCPHSCPHARMACEUTICALS INC$6.8M

Exited Positions (8)

TickerIssuerNotional
GBTGLOBAL BLOOD THERAPEUTICS IN$158.2M
RLMDRELMADA THERAPEUTICS INC$88.2M
TRAVERE THERAPEUTICS INC$46.0M
SGENSEAGEN INC$43.3M
EWEDWARDS LIFESCIENCES CORP$27.3M
ZYMEZYMEWORKS INC$27.1M
APLSAPELLIS PHARMACEUTICALS INC$25.0M
RCUSARCUS BIOSCIENCES INC$17.4M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
SRPTSAREPTA THERAPEUTICS INC$56.2M+156.6%-84.6%
MDGLPUTMADRIGAL PHARMACEUTICALS INC$190.9M+121.1%+85.0%
RCKTROCKET PHARMACEUTICALS INC$13.1M+115.6%
VERUXXXXVERU INC$-3.4M+101.8%
ATXSASTRIA THERAPEUTICS INC$21.0M+70.9%
BMRNBIOMARIN PHARMACEUTICAL INC$23.9M+50.5%-41.4%
AXGNAXOGEN INC$2.5M+46.2%
IMTXIMMATICS N.V$5.4M+39.7%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
NVRONEVRO CORP$-5.8M-80.0%
PRCTPROCEPT BIOROBOTICS CORP$-8.3M-75.5%
DICEDICE THERAPEUTICS INC$-4.8M-57.3%
HLVXHILLEVAX INC$-6.3M-46.9%
ISEEIVERIC BIO INC$-6.0M-43.2%
ALBOALBIREO PHARMA INC$-7.7M-25.5%
SWTXSPRINGWORKS THERAPEUTICS INC$-30.9M-24.6%
CRNXCRINETICS PHARMACEUTICALS IN$-30.6M-24.1%+133.3%
← Back to Hedge Funds